Psycho-social Determinant for Sport Practised During Cancer (PERTINENCE)

August 3, 2023 updated by: Institut de Cancérologie de Lorraine

Psychological and Social Determinants of Physical Activity Practice From Diagnose to Survival Among French Cancer Patients

The litterature has demonstrates that physical activity can play an important role in decreasing patient mortality rates and increasing its well-being at all time of cancer. Despite this evidence, there is a weak adhesion in patients. It is therefore appropriate to look and see which may explain the high prevalence of physical inactivity in patients with cancer. The main objective of this study will be to recognize psychological and social factors which could explain the commitment or not to a physical activity in cancer patients. Besides the physical limitations related to the cancer and its treatment, socio-economic and psycho-social factors can often play an extremely important role in engagement or maintenance of sporting activity.

Study Overview

Status

Recruiting

Detailed Description

Different individual factors have been identified as playing an important role in physical activity (PA) practice. For example, sex, age, education level, socio-professional category, ethnicity, overweight seemed to impact PA level in general population and among cancer patient.

Beyond the disease's effect, as well as its treatment, the socio-ecological approach has identified five group of factors associated to PA practice: individual factors, interpersonal factors, environmental factors, political factors and global factors.

The aim of this mixed methods study is to identify the variables of the socioecological model facilitating PA practice, as well as PA level and preferences at different time during cancer (at diagnose, during treatment, after treatment).

Study Type

Observational

Enrollment (Estimated)

693

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Metz, France
        • Recruiting
        • CHR Metz Thionville
        • Contact:
          • Raffaele LONGO, MD
      • Nancy, France
        • Recruiting
        • Institut de Cancérologie de Lorraine
        • Contact:
          • Didier Peiffert, Pr
      • Thionville, France
        • Recruiting
        • CHR Metz Thionville
        • Contact:
          • Nidal AL-AUKLA, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patient with an histollogically confirmed non-metastatic breast, prostate or colorectal cancer diagnosis, who had no started any treatment.

Description

Inclusion Criteria:

  • Major patient
  • With an histollogically confirmed non-metastatic (breast, prostate or colorectal) cancer diagnosis
  • To be addressed to an oncologist before the beginning of any treatment
  • Informed and having agreed to participate in the study
  • Operated patient without adjuvant therapy

Exclusion Criteria:

  • Presence of threatening bone lesion
  • physical, cognitive or linguistics incapacity to fulfil the questionnaire
  • With a life expectancy of less than 6 months
  • Pregnant woman
  • Under legal protection or deprived of liberty

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity
Time Frame: Day 1
The Questionnaire include four main section: medical, socio-economic variables, personality traits situational variables and physical activity. Sociological variables will encompass age, gender, education, and socio-professional category, and professional activity, marital and socio-economic status, place of living. Life habits and PA practice before diagnose will help to look at inter-determinants relationships. Medical data will also be collected from patient perspective. Situational variables will encompass passion, basic need satisfaction in sport, state-hope, self-determined motivation for PA, anxiety and depression. PA and sedentary behaviors will be measured using self-reported Global Physical Activity questionnaire. This questionnaire will measure the frequency, intensity, duration, as well as context of PA practice.
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity at 6 months
Time Frame: Month 6
The Questionnaire six months after the inclusion
Month 6
Physical activity at 12 months
Time Frame: Month 12
The Questionnaire one year after the inclusion
Month 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Tarquino Cyril, Pr, Centre Pierre Janet, Université de Lorraine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 9, 2019

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

April 15, 2019

First Submitted That Met QC Criteria

April 15, 2019

First Posted (Actual)

April 18, 2019

Study Record Updates

Last Update Posted (Actual)

August 4, 2023

Last Update Submitted That Met QC Criteria

August 3, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2018-08Obs-CHRMT

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

3
Subscribe